Evidence map›Paper›PMID 24308702›Full record

ArticleMicrocirculation (New York, N.Y. : 1994)2014

Extracellular ubiquitin increases expression of angiogenic molecules and stimulates angiogenesis in cardiac microvascular endothelial cells.

Rebecca J Steagall, Christopher R Daniels, Suman Dalal, William L Joyner, Mahipal Singh, Krishna Singh

Open access · greenAbstract read
In one paragraph

Article in Microcirculation (New York, N.Y. : 1994), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Almost 50 Years of Monomeric Extracellular Ubiquitin (eUb).Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Cardioprotective Potential of Exogenous Ubiquitin.Cardiovascular drugs and therapy · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. The role of ubiquitin in cardiac ischemia-reperfusion injury.American journal of physiology. Heart and circulatory physiology · 2019
    Article
  12. Article
  13. Review
  14. Antiangiogenic Effect of Alkaloids.Oxidative medicine and cellular longevity · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Potential Role of lncRNAs in Contributing to Pathogenesis of Intervertebral Disc Degeneration Based on Microarray Data.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Article
  19. Evaluating the Oxidative Stress in Inflammation: Role of Melatonin.International journal of molecular sciences · 2015
    Review
  20. Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Rebecca J SteagallDepartment of Biomedical Sciences, James H Quillen College of Medicine, James H Quillen Veterans Affairs Medical Center, East Tennessee State University, Johnson City, Tennessee, USA.
Christopher R Daniels
Suman Dalal
William L Joyner
Mahipal Singh
Krishna Singh
East Tennessee State University · US

Funding

Extracellular ubiquitin: role in myocyte apoptosis and myocardial remodelingR21HL092459 · NHLBI · EAST TENNESSEE STATE UNIVERSITY · PI SINGH, KRISHNA · 2009 to 2010
$392k
Role of ATM in Cardiac Myocyte Loss and Myocardial RemodelingR21HL091405 · NHLBI · EAST TENNESSEE STATE UNIVERSITY · PI SINGH, KRISHNA · 2008 to 2009
$391k
ER stress: role in myocyte apoptosis and myocardial remodelingI01BX000640 · VA · JAMES H QUILLEN VA MEDICAL CENTER · PI SINGH, KRISHNA · 2011 to 2013
–
BLRD VA I01 BX000640NHLBI NIH HHS R21 HL091405NHLBI NIH HHS R21HL-091405NHLBI NIH HHS R21 HL092459NHLBI NIH HHS R21HL-092459
6 · The paper itself

Abstract

Extracellular Ub is an immune modulator that plays a role in suppression of inflammation, organ injury, myocyte apoptosis, and fibrosis. The purpose of this study was to investigate the effects of extracellular Ub on the process of cardiac angiogenesis. CMECs and aortic tissue were isolated from rats to measure changes in angiogenic protein levels and to assess angiogenic responses to extracellular Ub. In CMECs, extracellular Ub increased protein levels of VEGF-A and MMP-2, known angiogenesis regulators. CMECs demonstrated enhanced rearrangement of fibrillar actin and migration in response to Ub treatment. Ub-treated CMECs demonstrated an increase in tube network formation which was inhibited by the CXCR4 receptor antagonist, AMD3100. Methylated Ub, unable to form polyubiquitin chains, enhanced tube network formation. Aortic ring sprouting assays demonstrated that Ub increases microvessel sprouting in the Matrigel. The results of our study suggest a novel role for extracellular Ub in cardiac angiogenesis, providing evidence that extracellular Ub, at least in part acting via the CXCR4 receptor, has the potential to facilitate the process of angiogenesis in myocardial endothelial cells.

Indexed as

AnimalsCells, CulturedCoronary VesselsEndothelial CellsMaleMatrix Metalloproteinase 2MicrovesselsNeovascularization, PhysiologicRatsRats, Sprague-DawleyUbiquitinVascular Endothelial Growth Factor AMatrix Metalloproteinase 2Mmp2 protein, ratUbiquitinVascular Endothelial Growth Factor Avascular endothelial growth factor A, ratangiogenesiscardiac microvascular endothelial cellsheartubiquitinVEGF-A

Identifiers

PMID24308702
PMCPMC4032614
OpenAlexW1996620227

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.